RAJAF (Cordyceps Sunshine Biotech Holdings Co) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cordyceps Sunshine Biotech Holdings Co Change In Payables And Accrued Expense?

Cordyceps Sunshine Biotech Holdings Co's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $0.00 Mil. It means Cordyceps Sunshine Biotech Holdings Co's Accounts Payable & Accrued Expense stayed the same from Sep. 2023 to Dec. 2023 .

Cordyceps Sunshine Biotech Holdings Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $0.13 Mil. It means Cordyceps Sunshine Biotech Holdings Co's Accounts Payable & Accrued Expense increased by $0.13 Mil from Dec. 2022 to Dec. 2023 .

Cordyceps Sunshine Biotech Holdings Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Cordyceps Sunshine Biotech Holdings Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordyceps Sunshine Biotech Holdings Co Change In Payables And Accrued Expense Chart

Cordyceps Sunshine Biotech Holdings Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

-0.01

0.13

Cordyceps Sunshine Biotech Holdings Co Quarterly Data
	Dec20	Dec21	Dec22	Sep23	Dec23
Change In Payables And Accrued Expense	-	-	-	-	-

Cordyceps Sunshine Biotech Holdings Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Cordyceps Sunshine Biotech Holdings Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cordyceps Sunshine Biotech Holdings Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cordyceps Sunshine Biotech Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cordyceps Sunshine Biotech Holdings Co Ltd (OTCPK:RAJAF) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 548, Ruiguang Road, 6th Floor, No. 15, Neihu District, Taipei City, TWN

Website

http://www.cordyceps-sunshine.com

Cordyceps Sunshine Biotech Holdings Co Ltd engages in cultivating Chinese rare medicinal herbs, Cattle camphor mushroom raw materials, and selling its finished products. The company has one business segment: cultivating and sales of Chinese rare medicinal herb, taiwanofungus raw material, and its finished products. The company generates revenue from product sales, training, and related parties.

Cordyceps Sunshine Biotech Holdings Co Headlines

No Headlines